| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.923.609 | 2.028.734 | 3.059.055 | 3.141.245 | 4.579.699 | 4.966.702 | 5.402.043 | 4.683.290 | 4.893.564 | 5.088.921 |
| Total Income - EUR | 2.035.528 | 2.156.855 | 3.358.152 | 3.784.977 | 4.796.341 | 5.935.094 | 5.897.847 | 5.215.133 | 5.448.769 | 5.729.685 |
| Total Expenses - EUR | 2.230.321 | 2.476.677 | 3.390.343 | 4.221.423 | 5.496.987 | 5.931.976 | 5.940.133 | 5.512.386 | 5.350.430 | 5.790.191 |
| Gross Profit/Loss - EUR | -194.793 | -319.822 | -32.192 | -436.446 | -700.646 | 3.118 | -42.286 | -297.254 | 98.340 | -60.505 |
| Net Profit/Loss - EUR | -194.793 | -319.822 | -118.332 | -436.446 | -700.646 | 3.118 | -42.286 | -297.254 | 55.715 | -65.011 |
| Employees | 38 | 45 | 64 | 74 | 95 | 97 | 96 | 85 | 84 | 80 |
Check the financial reports for the company - Cegedim Rx Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.308.633 | 1.657.408 | 2.098.692 | 3.436.274 | 3.134.736 | 3.243.222 | 2.736.494 | 2.597.787 | 2.963.123 | 3.027.709 |
| Current Assets | 611.091 | 749.229 | 1.240.958 | 1.654.389 | 1.564.560 | 1.293.221 | 1.002.354 | 966.714 | 1.052.007 | 1.345.325 |
| Inventories | 200.658 | 188.064 | 242.102 | 263.922 | 118.284 | 117.907 | 135.038 | 109.408 | 163.321 | 226.212 |
| Receivables | 336.125 | 470.383 | 806.652 | 1.267.611 | 1.313.557 | 987.218 | 672.124 | 682.881 | 728.024 | 1.006.541 |
| Cash | 74.308 | 90.782 | 192.204 | 122.855 | 132.719 | 188.095 | 195.192 | 174.424 | 160.662 | 112.572 |
| Shareholders Funds | 246.566 | -75.771 | -192.821 | 1.444.952 | 716.323 | 1.506.638 | 1.430.940 | 1.138.126 | 1.190.390 | 997.169 |
| Social Capital | 4.499 | 4.454 | 4.378 | 2.074.978 | 2.034.794 | 2.796.996 | 1.469.370 | 1.473.929 | 1.469.459 | 1.461.247 |
| Debts | 1.669.587 | 2.483.689 | 3.602.959 | 3.678.767 | 3.915.197 | 3.042.216 | 2.287.710 | 2.377.351 | 2.772.261 | 3.233.879 |
| Income in Advance | 6.081 | 0 | 1.251 | 440 | 108 | 15.241 | 13.481 | 8.670 | 8.896 | 67.636 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5829 - 5829" | |||||||||
| CAEN Financial Year |
5829
|
|||||||||
Comments - Cegedim Rx Srl